Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzalutamide Monotherapy in Hormone-Naïve Prostate Cancer
NCT01302041Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- May 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of enzalutamide in prostate cancer (PCa), sponsored by Astellas Pharma. Started May 2011; status: completed.
02
Drugs
enzalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01302041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01302041.